CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 420 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,634 | -75.9% | 135,947 | -70.3% | 0.01% | -76.0% |
| Q2 2023 | $25,656,428 | +3503.4% | 457,008 | +4095.4% | 0.05% | +2400.0% |
| Q3 2022 | $712,000 | -97.5% | 10,893 | -95.7% | 0.00% | -98.3% |
| Q3 2021 | $28,624,000 | +35238.3% | 255,727 | +13240.0% | 0.12% | +11800.0% |
| Q1 2020 | $81,000 | -44.1% | 1,917 | -19.3% | 0.00% | 0.0% |
| Q4 2019 | $145,000 | -31.6% | 2,374 | -48.7% | 0.00% | -88.9% |
| Q1 2018 | $212,000 | – | 4,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |